Cyclopharm Limited (CYCLOPHARM FPO [CYC]) Aktie
CYC.AX
$0.6750+0.0100 (+1.50%)
Chart wird geladen...
CYCLOPHARM FPO [CYC]
Market Cap
$85,094,408
Eröffnung0.6850
Hoch0.7050
Tief0.6750
Volumen5.28k
P/EN/A
Marktkapitalisierung85.09M
52-Wochen-Hoch1.2900
52-Wochen-Tief0.5600
Durchschn. Volumen65.77k
DividendeN/A
Beta0.59
EPS-0.1600
Über Cyclopharm Limited (CYCLOPHARM FPO [CYC]) Aktie
Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, the United States, and internationally. The company operates Technegas which offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and other respiratory conditions. It is also involved in the research and development; and distribution of third-party products to the diagnostic imaging sector. The company serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is based in Kingsgrove, Australia.
Unternehmensinformationen
Börse: ASX (ASX)
Sektor: Sundhed
Branche: Medicinsk distribution
Adresse:
1 The Crescent
2208 Kingsgrove, Australia
2208 Kingsgrove, Australia
Telefon: + 61 2 9541 0411
Analystenempfehlungen
Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.
Niedrigstes Kursziel
1.01
↑ 49.3%
Durchschnittliches Kursziel
1.01
↑ 49.3%
Median Kursziel
1.01
↑ 49.3%
Höchstes Kursziel
1.01
↑ 49.3%